IUPAC/Chemical Name
(1S,7R,7aS,14R,14aS)-dodecahydro-2H,6H-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocin-1-ol
InChi Key
JMXNBIDTNISOTA-MRLBHPIUSA-N
InChi Code
InChI=1S/C15H26N2O/c18-14-5-3-7-17-9-11-8-12(15(14)17)10-16-6-2-1-4-13(11)16/h11-15,18H,1-10H2/t11-,12-,13+,14+,15+/m1/s1
SMILES Code
O[C@H]1CCCN2C[C@H]3C[C@@H]([C@@H]12)CN4CCCC[C@@H]34
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
250.38
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: RAYMOND-HAMET. [Action of retamine on the effect on blood pressure and the heart of faradization of the peripheral end of the vagus and of compression of the carotid]. C R Seances Soc Biol Fil. 1955 Jun;149(11-12):1239-42. French. PubMed PMID: 13277278.
2: OTTAVIANO G, STEINEGGER E, BERNASCONI R. [CHEMICAL AND PHARMACOLOGICAL RESEARCH ON ONE OF THE ACTIVE PRINCIPLES OF GENISTA AETNENSIS: RETAMINE]. Arch Int Pharmacodyn Ther. 1964 Apr 1;148:404-18. Italian. PubMed PMID: 14181235.
3: RAYMOND HAMET. [Sparteine-like properties of retamine]. C R Hebd Seances Acad Sci. 1955 May 23;240(21):2092-4. French. PubMed PMID: 14390797.
4: FAUGERAS G, PARIS RR. [ON THE ALKALOIDS OF GENISTA RADIATA SCOP. ISOLATION OF RETAMINE AND D-SPARTEINE]. C R Hebd Seances Acad Sci. 1964 Dec 21;259:4861-4. French. PubMed PMID: 14254950.
5: Pellón A, Mosquera R, Castedo L, Ribas I. Retamine N-oxides. Tetrahedron Lett. 1969 Jan;(3):129-32. PubMed PMID: 5778487.
6: SANDBERG F, INGELMAN-SUNDBERG A, LINDGREN L, RYDEN G. In vitro studies of the motility of the human uterus. Part V--The effects of L-sparteine. D-sparteine and retamine (7-hydroxysparteine) on the spontaneous motility in different parts of the pregnant and non-pregnant uterus. J Obstet Gynaecol Br Emp. 1959 Dec;66:939-45. PubMed PMID: 14441364.
7: Orhan I, Naz Q, Kartal M, Tosun F, Sener B, Choudhary MI. In vitro anticholinesterase activity of various alkaloids. Z Naturforsch C. 2007 Sep-Oct;62(9-10):684-8. PubMed PMID: 18069241.
8: DEL RIO IBANEZ J, RUIZ-GIJON J. [Pharmacological study of retamine and other alkaloids of Retama sphaerocarpa Boiss]. Farmacognosia. 1952 Apr-Jun;12(24):183-8. PubMed PMID: 12989167.
9: TRUTNEVA EA. [Pharmacology of retamine]. Farmakol Toksikol. 1958 Sep-Oct;21(5):46-51. Russian. PubMed PMID: 13609685.
10: Wink M, Witte L. Quinolizidine alkaloids inGenista acanthoclada and its holoparasite,Cuscuta palaestina. J Chem Ecol. 1993 Mar;19(3):441-8. doi: 10.1007/BF00994317. PubMed PMID: 24248948.
11: Pistelli L, Bertoli A, Giachi I I, Morelli I I, Rubiolo P, Bicchi C. Quinolizidine alkaloids from Genista ephedroides. Biochem Syst Ecol. 2001 Feb 1;29(2):137-141. PubMed PMID: 11106841.
12: Martin Cordero C, Gil Serrano AM, Ayuso Gonzalez MJ. Transfer of bipiperidyl and quinolizidine alkaloids toViscum cruciatum Sieber (Loranthaceae) hemiparasitic onRetama sphaerocarpa boissier (Leguminosae). J Chem Ecol. 1993 Oct;19(10):2389-93. doi: 10.1007/BF00979672. PubMed PMID: 24248584.
